Project Grant R21EB037336
- Federal Project Grant Award Summary The University of Oregon received a $398,464 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective May 1, 2026, through March 31, 2031. This award supports the development of photodynamic biomaterials designed to advance microphysiological tissue engineering by enabling precise spatial and temporal control over three-dimensional (3D) tissue growth...
- Federal Grant Award Summary Oregon Health & Science University received a $662,913 Project Grant award from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286), effective August 1, 2025, through July 31, 2029. The research focuses on developing a peptide amphiphile (PA)-based universal drug delivery platform designed to address significant limitations of...
- Federal Grant Award Summary Oregon State University received a $399,081 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. This five-year research initiative focuses on elucidating the molecular mechanisms of lipid transfer mediated by bridge-like lipid transfer proteins (BLTPs), which are essential for fundamental cellular processes...
- Federal Project Grant Award Summary Oregon State University received a $408,375 Project Grant from the National Institute of General Medical Sciences under the Biomedical Research and Research Training program (CFDA 93.859), awarded March 1, 2026, with completion scheduled for February 29, 2028. This high-risk/high-reward initiative will develop and optimize Thermal Ink Jet Spray (TIJ Spray), a novel ionization source technology that enables direct injection of low-input biological samples,...
- Federal Grant Award Summary The National Institute of Biomedical Imaging and Bioengineering (NIBIB) awarded $624,000 through the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286) to The Regents of The University of Colorado-Denver for a two-year project period (April 1, 2026 – March 31, 2028). The project involves development and validation of a novel biomedical technology designed to improve heart transplant outcomes and expand the...
- Federal Grant Award Summary The Ohio State University received a $416,726 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 11, 2025, with a completion date of August 31, 2030. The award supports the development of mass spectrometry-based technologies to enable chemical and proteomic analysis of organoids—three-dimensional cell cultures derived directly from human or...
- Federal Project Grant Award Summary Oregon Health & Science University (OHSU) received a $390,000 Project Grant award from the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), effective September 1, 2025 through August 31, 2030. The grant supports the development of advanced methodologies for high-throughput deep characterization of extracellular RNA (cfRNA), cell-free DNA (cfDNA), and extracellular vesicles...
- Federal Grant Award Summary Oregon Health & Science University received a $1.24 million Project Grant from the National Institute of Dental and Craniofacial Research (NIDCR) under the Oral Diseases and Disorders Research program (CFDA 93.121), awarded June 13, 2025, with completion targeted for June 12, 2027. The project focuses on developing short-wave infrared (SWIR) fluorophores to enhance intraoperative visualization of buried nerves during head and neck cancer surgery. Current...
- Federal Project Grant Award Summary The University of Washington received a $548,298 CAREER (Faculty Early Career Development) award from the National Science Foundation's Division of Chemical, Bioengineering, Environmental, and Transport Systems under the Engineering program (CFDA 47.041), effective June 1, 2026 through May 31, 2031. This project grant funds research to develop innovative technologies for long-term organ cryopreservation through electromagnetic waves-facilitated vitrification...
- Federal Project Grant Award Summary Oregon State University received a $200,000 Project Grant awarded April 1, 2026, by the National Science Foundation's Division of Materials Research under the Mathematical and Physical Sciences program (CFDA 47.049). This collaborative research initiative focuses on elucidating the structure and function of direct delivery peptides—a novel class of molecules capable of efficiently transporting cargo across cell membranes without endocytic entrapment. The...
Oregon State University received a $560,293 Project Grant from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) under the Discovery and Applied Research for Technological Innovations to Improve Human Health program (CFDA 93.286). The three-year award, effective June 1, 2026 through May 31, 2029, supports research to develop novel cryopreservation methods that extend organ viability from hours to years. The project employs high-throughput screening and machine learning approaches to discover next-generation cryoprotective agents (CPAs) that overcome the toxicity limitations of existing compounds, thereby advancing organ transplantation capabilities. The research aims to enable more effective organ allocation, reduce discard rates, improve immunological matching, reduce chronic rejection, and increase surgical scheduling flexibility. This technology development effort aligns with NIBIB's mission to support hypothesis-driven and technology-driven research that advances biomedical engineering solutions for disease prevention, detection, diagnosis, and treatment. The project will be conducted at Oregon State University's Corvallis, Oregon location, leveraging the institution's established research capabilities in biotechnology and bioengineering.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $560.3k | 5/8/26 |